Lung transplantation for patients with severe COVID-19

Access Granted
Updated October 18, 2024

Lung transplantation can potentially be a life-saving treatment for patients with nonresolving COVID-19-associated respiratory failure. Concerns limiting lung transplantation include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and the potential risk for allograft infection by pathogens causing ventilator-associated pneumonia in the native lung. Additionally, the native lung might recover, resulting in long-term outcomes preferable to those of transplant. Here, we report the results of lung transplantation in three patients with nonresolving COVID-19-associated respiratory failure. We performed single-molecule fluorescence in situ hybridization (smFISH) to detect both positive and negative strands of SARS-CoV-2 RNA in explanted lung tissue from the three patients and in additional control lung tissue samples. We conducted extracellular matrix imaging and single-cell RNA sequencing on explanted lung tissue from the three patients who underwent transplantation and on warm postmortem lung biopsies from two patients who had died from COVID-19-associated pneumonia. Lungs from these five patients with prolonged COVID-19 disease were free of SARS-CoV-2 as detected by smFISH, but pathology showed extensive evidence of injury and fibrosis that resembled end-stage pulmonary fibrosis. Using machine learning, we compared single-cell RNA sequencing data from the lungs of patients with late-stage COVID-19 to that from the lungs of patients with pulmonary fibrosis and identified similarities in gene expression across cell lineages. Our findings suggest that some patients with severe COVID-19 develop fibrotic lung disease for which lung transplantation is their only option for survival.

Ankit BharatNorthwestern University, Northwestern Memorial Hospitalabharat@nm.org
Ankit Bharat1
Melissa Querrey1
Nikolay S Markov1
Samuel Kim1
Chitaru Kurihara1
Rafael Garza-Castillon1
Adwaiy Manerikar1
Ali Shilatifard1
Rade Tomic1
Yuliya Politanska1
Hiam Abdala-Valencia1
Anjana V Yeldandi1
Jon W Lomasney1
Alexander V Misharin1
G R Scott Budinger1
1Northwestern University, Northwestern Memorial Hospital
Ida Zucchi

To reference this project, please use the following link:

https://explore.data.humancellatlas.org/projects/5a54c617-0eed-486e-8c1a-8a8041fc1729

Supplementary links are provided by contributors and represent items such as additional data which can’t be hosted here; code that was used to analyze this data; or tools and visualizations associated with this specific dataset.

1.https://github.com/NUPulmonary/2020_Bharat2.https://www.nupulmonary.org/covid-19/3.https://zenodo.org/record/4291961
GEO Series Accessions:INSDC Study Accessions:

Atlas

LungLung v1.0

Analysis Portals

None

Project Label

LungTransplantationCOVID-19

Species

Homo sapiens

Sample Type

specimens

Anatomical Entity

lung

Organ Part

2 organ parts

Selected Cell Types

5 cell types

Disease Status (Specimen)

7 disease statuses

Disease Status (Donor)

10 disease statuses

Development Stage

human adult stage

Library Construction Method

10x 3' v3

Nucleic Acid Source

single cell

Paired End

false

Analysis Protocol

filtered_matrix, merging_matrices, raw_matrix_generation

File Format

4 file formats

Cell Count Estimate

92.0k

Donor Count

5
csv.gz4 file(s)h5.gz44 file(s)h5ad.gz4 file(s)xlsx1 file(s)
HCA Data PortalHCA Data Portal
AboutHelpPrivacyContact
v2.15.0-2d1a042-dcp46